Edition:
United Kingdom

India's Alembic Pharma Sept-qtr consol PAT rises


Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Alembic Pharmaceuticals Ltd ::Says U.S. formulations business continues to face price erosion on some key products; India branded business showing signs of recovery‍​‍​.Sept quarter consol PAT 1.22 billion rupees versus 1.20 billion rupees year ago.Sept quarter consol revenue from operations 7.89 billion rupees versus 8.79 billion rupees year ago. 

Related Company News

Company Quote

565.15
-15.2 -2.62%
9:59am GMT